Literature DB >> 23160735

Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging.

J Zemva1, M Udelhoven, L Moll, S Freude, O Stöhr, H S Brönneke, R B Drake, W Krone, M Schubert.   

Abstract

The insulin receptor substrates (IRS) are adapter proteins mediating insulin's and IGF1's intracellular effects. Recent data suggest that IRS2 in the central nervous system (CNS) is involved in regulating fuel metabolism as well as memory formation. The present study aims to specifically define the role of chronically increased IRS2-mediated signal transduction in the CNS. We generated transgenic mice overexpressing IRS2 specifically in neurons (nIRS2 (tg)) and analyzed these in respect to energy metabolism, learning, and memory. Western blot (WB) analysis of nIRS2 (tg) brain lysates revealed increased IRS2 downstream signaling. Histopathological investigation of nIRS2 (tg) mice proved unaltered brain development and structure. Interestingly, nIRS2 (tg) mice showed decreased voluntary locomotoric activity during dark phase accompanied with decreased energy expenditure (EE) leading to increased fat mass. Accordingly, nIRS2 (tg) mice develop insulin resistance and glucose intolerance during aging. Exploratory behavior, motor function as well as food and water intake were unchanged in nIRS2 (tg) mice. Surprisingly, increased IRS2-mediated signals did not change spatial working memory in the T-maze task. Since FoxO1 is a key mediator of IRS2-transmitted signals, we additionally generated mice expressing a dominant negative mutant of FoxO1 (FoxO1DN) specifically in neurons. This mutant mimics the effect of increased IRS2 signaling on FoxO-mediated transcription. Interestingly, the phenotype observed in nIRS2 (tg) mice was not present in FoxO1DN mice. Therefore, increased neuronal IRS2 signaling causes decreased locomotoric activity in the presence of unaltered exploratory behavior and motor coordination that might lead to increased fat mass, insulin resistance, and glucose intolerance during aging independent of FoxO1-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160735      PMCID: PMC3776092          DOI: 10.1007/s11357-012-9491-x

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  52 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

Authors:  Mandip S Dhamoon; James M Noble; Suzanne Craft
Journal:  Neurology       Date:  2009-01-20       Impact factor: 9.910

3.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

Authors:  Aileen M Moloney; Rebecca J Griffin; Suzanne Timmons; Rosemary O'Connor; Rivka Ravid; Cora O'Neill
Journal:  Neurobiol Aging       Date:  2010-02       Impact factor: 4.673

4.  Reduced IGF-1 signaling delays age-associated proteotoxicity in mice.

Authors:  Ehud Cohen; Johan F Paulsson; Pablo Blinder; Tal Burstyn-Cohen; Deguo Du; Gabriela Estepa; Anthony Adame; Hang M Pham; Martin Holzenberger; Jeffery W Kelly; Eliezer Masliah; Andrew Dillin
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

Review 5.  The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.

Authors:  S Freude; K Schilbach; M Schubert
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

6.  Foxo1 integrates insulin signaling with mitochondrial function in the liver.

Authors:  Zhiyong Cheng; Shaodong Guo; Kyle Copps; Xiaochen Dong; Ramya Kollipara; Joseph T Rodgers; Ronald A Depinho; Pere Puigserver; Morris F White
Journal:  Nat Med       Date:  2009-10-18       Impact factor: 53.440

7.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.

Authors:  Xiaocheng C Dong; Kyle D Copps; Shaodong Guo; Yedan Li; Ramya Kollipara; Ronald A DePinho; Morris F White
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

8.  Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.

Authors:  Susanna Freude; Moritz M Hettich; Christina Schumann; Oliver Stöhr; Linda Koch; Christoph Köhler; Michael Udelhoven; Uschi Leeser; Marita Müller; Naoto Kubota; Takashi Kadowaki; Wilhelm Krone; Hannsjörg Schröder; Jens C Brüning; Markus Schubert
Journal:  FASEB J       Date:  2009-06-01       Impact factor: 5.191

9.  IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.

Authors:  Susanna Freude; Uschi Leeser; Marita Müller; Moritz M Hettich; Michael Udelhoven; Katharina Schilbach; Kazuyuki Tobe; Takashi Kadowaki; Christoph Köhler; Hannsjörg Schröder; Wilhelm Krone; Jens C Brüning; Markus Schubert
Journal:  J Neurochem       Date:  2008-09-18       Impact factor: 5.372

10.  Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice.

Authors:  Richard Killick; Georgie Scales; Karelle Leroy; Mirsada Causevic; Claudie Hooper; Elaine E Irvine; Agharul I Choudhury; Laura Drinkwater; Fiona Kerr; Hind Al-Qassab; John Stephenson; Zehra Yilmaz; K Peter Giese; Jean-Pierre Brion; Dominic J Withers; Simon Lovestone
Journal:  Biochem Biophys Res Commun       Date:  2009-06-10       Impact factor: 3.575

View more
  5 in total

Review 1.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 2.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 3.  Tissue-specific insulin signaling in the regulation of metabolism and aging.

Authors:  Jingjing Zhang; Feng Liu
Journal:  IUBMB Life       Date:  2014-08-04       Impact factor: 3.885

4.  Deciphering Brain Insulin Receptor and Insulin-Like Growth Factor 1 Receptor Signalling.

Authors:  A Kleinridders
Journal:  J Neuroendocrinol       Date:  2016-11       Impact factor: 3.627

5.  AGING, HEART RATE VARIABILITY AND METABOLIC IMPACT OF OBESITY.

Authors:  Marina Rastović; Biljana Srdić-Galić; Otto Barak; Edita Stokić; Snežana Polovina
Journal:  Acta Clin Croat       Date:  2019-09       Impact factor: 0.780

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.